ILLUMINA VENTURES

ILLUMINA VENTURES
News

Illumina Ventures Closes $325 Million Fund

Genomics-Focused Fund Will Support Start-Ups in Healthcare Innovation

"Genomics and precision medicine are revolutionizing the healthcare industry," said Nick Naclerio, Illumina Ventures' Founding Partner. "This larger fund enables us to pursue more ambitious projects in the US and Europe while building upon the strategies and core values that have been successful in the past."

Imagine How Genomics Will Transform Our Future.